Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CellMed AG

Division of Boston Scientific Corp.
www.cellmed.com

Latest From CellMed AG

Cell-Based Solutions for Neurologic Disease

Emerging tissue-engineering and cell transplantation therapies have the potential to provide solutions to many of the treatment challenges facing neurologists today.
BioPharmaceutical Medical Device

Cosmetic Dermatology Thrives in Spite of Economy

While other medical device sectors, such as orthopedics and invasive plastic surgery, experienced a downturn in elective procedures in 2009, cosmetic dermatology procedures--including Botox and facial filler injections--continue on their upward trend. This fact was emphasized by the record attendance at the American Academy of Dermatology summer meeting held in Chicago in August 2010.
Medical Device

New Stem Cell Therapies

Recent research advances and relaxation of government restrictions have opened the stem cell field to product possibilities. Companies developing these potentially revolutionary products must also come up with workable business models. In this issue we profile five emerging contenders: Amorcyte, California Stem Cell, Cardio3 BioSciences, CellDesign and Fate Therapeutics.
BioPharmaceutical Strategy

Biocompatibles: Crossing Over to the Convergence Side in Cancer and Stroke

Biocompatibles has re-invented itself a third time, exiting traditional device markets for riskier drug-device convergence plays in oncology and stroke, clinical areas dominated by drug therapy. This move has caught drug companies' attention clinically, but will Big Pharma validate Biocompatibles' strategy commercially?
Medical Device Innovation
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Implantable Devices
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Dermatology
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Boston Scientific Corp.
  • Senior Management
  • Peter Geigle, Dir.
  • Contact Info
  • CellMed AG
    Phone: (49) 6023 9181 0
    Industriestr. 19
    Alzenau, D-63755
    Germany
UsernamePublicRestriction

Register